Provided by Tiger Trade Technology Pte. Ltd.

Annovis Bio, Inc.

1.17
0.0000
Volume:244.63K
Turnover:281.62K
Market Cap:49.77M
PE:-0.65
High:1.20
Open:1.19
Low:1.14
Close:1.17
52wk High:5.50
52wk Low:1.04
Shares:42.54M
Float Shares:35.55M
Volume Ratio:1.59
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7895
EPS(LYR):-1.4040
ROE:-703.68%
ROA:-142.36%
PB:-11.70
PE(LYR):-0.83

Loading ...

Annovis Bio Completes Enrollment in Pivotal Alzheimer’s Trial

TIPRANKS
·
Jul 10

Annovis Bio Completes Enrollment in Phase 3 Early Alzheimer’s Trial of Buntanetap

Reuters
·
Jul 10

Analysts’ Top Healthcare Picks: Evolus (EOLS), Annovis Bio (ANVS)

TIPRANKS
·
Jul 09

Annovis Bio Initiated at Buy by Roth Capital

Dow Jones
·
Jul 08

Annovis Bio initiated with a Buy at Roth Capital

TIPRANKS
·
Jul 08

Annovis Bio announces full enrollment for buntanetap trial

TIPRANKS
·
Jul 07

Annovis Bio Reaches Full Enrollment in Phase 3 Early Alzheimer’s Trial of Buntanetap

Reuters
·
Jul 07

Annovis Bio - Symptomatic Data Readout Expected Q1 2027, Disease-modifying Data Readout Expected Q1 2028

THOMSON REUTERS
·
Jul 07

Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease

THOMSON REUTERS
·
Jul 07

Annovis Bio - Preparing for Two Nda Submissions Following Data Readouts

THOMSON REUTERS
·
Jul 07

Press Release: Annovis Appoints Cheng Fang, Ph.d., as Chief Scientific Officer

Dow Jones
·
Jul 01

Annovis Bio Shareholders Approve Governance and Compensation Changes

TIPRANKS
·
Jun 18

Annovis Bio shareholders approve 2019 equity plan share increase to 5.5 million

Reuters
·
Jun 18

Annovis Bio: Buy Rating Reiterated as Late-Stage Neurodegenerative Pipeline Advances; $8 Price Target Unchanged

TIPRANKS
·
May 29

Annovis Bio Regains Nyse Listing Compliance

THOMSON REUTERS
·
May 26

Annovis Bio Regains NYSE Listing Compliance

GlobeNewswire
·
May 26

Annovis Bio director Michael B Hoffman buys $141,027 of common shares

Reuters
·
May 22

Annovis Bio Announces Dilutive Equity Offering for Trials

TIPRANKS
·
May 21

BRIEF-Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants

Reuters
·
May 20

Annovis Bio 7.9M share Spot Secondary priced at $1.90

TIPRANKS
·
May 20